The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Assessing Toxicity of Fine and Nanoparticles: Comparing In Vitro Measurements to In Vivo Pulmonary Toxicity Profiles
Abstract
Previous studies have reported little correlation between the relative toxicity of particle types when comparing lung toxicity rankings following in vivo instillation versus in vitro cell culture exposures. This study was designed to assess the capacity of in vitro screening studies to predict in vivo pulmonary toxicity of several fine or nanoscale particle types in rats. In the in vivo component of the study, rats were exposed by intratracheal instillation to 1 or 5 mg/kg of the following particle types: (1) carbonyl iron (CI), (2) crystalline silica (CS) (Min-U-Sil 5, alpha-quartz), (3) precipitated amorphous silica (AS), (4) nano-sized zinc oxide (NZO), or (5) fine-sized zinc oxide (FZO). Depending on particle type and solution state, these particles range in size from 90 to 500 nm in size. Following exposures, the lungs of exposed rats were lavaged and inflammation (neutrophil recruitment) and cytotoxicity end points (bronchoalveolar lavage [BAL] fluid lactate dehydrogenase [LDH] values) were measured at 24 h, 1 week, 1 and 3 months postexposure. For the in vitro component of the study, three different culture conditions were utilized. Cultures of (1) rat L2 lung epithelial cells, (2) primary alveolar macrophages (AMs) (collected via BAL from unexposed rats), as well as (3) AM-L2 lung epithelial cell cocultures were incubated with the particle types listed above, and the culture fluids were evaluated for cytotoxicity end points (LDH, 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan [MTT]) as well as inflammatory cytokines (macrophage inflammatory 2 protein [MIP-2], tumor necrosis factor alpha [TNF-alpha], and interleukin-6 [IL-6]) at one (i.e., cytokines) or several (cytotoxicity) time periods. Results of in vivo pulmonary toxicity studies demonstrated that instilled CI particles produced little toxicity. CS particles produced sustained inflammation and cytotoxicity. AS particles produced reversible and transient inflammatory responses. NZO or FZO particles produced potent but reversible inflammation which was resolved by 1 month postinstillation exposure. Results of in vitro pulmonary cytotoxicity studies demonstrated a variety of responses to the different particle types, primarily at high doses. With respect to the LDH results, L2 cells were the most sensitive and exposures to nano- or fine-sized ZnO for 4 or 24 h were more cytotoxic than exposures to CS or AS particles. Macrophages essentially were resistant and epithelial macrophage cocultures generally reflected the epithelial results at 4 and 24 h incubation, but not at 48 h incubation. MTT results were also interesting but, except for nano- and fine-sized ZnO, did not correlate well with LDH results. Results of in vitro pulmonary inflammation studies demonstrated that L2 cells did not produce MIP-2 cytokines, but CS- or AS-exposed AMs and, to a lesser degree, cocultures secreted these chemotactic factors into the culture media. Measurements of TNF-alpha in the culture media by particle-exposed cells demonstrated little activity. In addition, IL-6 secretion was measured in CS, AS, and nano-sized ZnO-exposed cocultures. When considering the range of toxicity end points to five different particle types, the comparisons of in vivo and in vitro measurements demonstrated little correlation, particularly when considering many of the variables assessed in this study-such as cell types to be utilized, culture conditions and time course of exposure, as well as measured end points. It seems clear that in vitro cellular systems will need to be further developed, standardized, and validated (relative to in vivo effects) in order to provide useful screening data on the relative toxicity of inhaled particle types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Adsorption of Gases in Multimolecular Layers
Brunauer, S., Emmett, P. H., & Teller, E. (1938) · Journal of the American Chemical Society · doi:10.1021/ja01269a023 · Cited by 28,156
Dynamic Light Scattering: Applications of Photon Correlation Spectroscopy
(1985) · Springer eBooks · doi:10.1007/978-1-4613-2389-1 · Cited by 4,856
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.1 · Cited by 2,069
Safe handling of nanotechnology
Maynard, A. D., Aitken, R. J., Butz, T., Colvin, V., Donaldson, K., Oberdörster, G., Philbert, M. A., Ryan, J., Seaton, A., Stone, V., et al. (2006) · Nature · doi:10.1038/444267a · Cited by 1,496
Self-citationBiological and clinical aspects of interleukin 6
Hirano, T., Akira, S., Taga, T., & Kishimoto, T. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90173-7 · Cited by 1,066
Macromolecular Crystallography Part A
(1997) · Methods in Enzymology · doi:10.1016/s0076-6879(00)x0162-0 · Cited by 784
Pesce, A. J., & Kaplan, L. A. (1987) · Mosby eBooks · Cited by 452
Identification and characterization of macrophage inflammatory protein 2.
Wolpe, S. D., Sherry, B., Juers, D., Davatelis, G., Yurt, R. W., & Cerami, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.612 · Cited by 425
Widmer, U., Manogue, K. R., Cerami, A., & Sherry, B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.4996 · Cited by 251
BEUTLER, B., & CERAMI, A. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-57 · Cited by 251
Journey from cachexia to obesity by TNF
Argilés, J. M. A., López‐Soriano, J., Busquets, S., & López-Soriano, F. J. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.10.9271359 · Cited by 131
Seagrave, J., McDonald, J. D., Gigliotti, A. P., Nikula, K. J., Seilkop, S. K., Gurevich, M., & Mauderly, J. L. (2002) · Toxicological Sciences · doi:10.1093/toxsci/70.2.212 · Cited by 119
Deposition pattern of inorganic particles at the alveolar level in the lungs of rats and mice.
Brody, A. R., & Roe, M. W. (1983) · PubMed · doi:10.1164/arrd.1983.128.4.724 · Cited by 104
Pulmonary Macrophages Are Attracted to Inhaled Particles through Complement Activation
Warheit, D. B., Overby, L. H., George, G., & Brody, A. R. (1988) · Experimental Lung Research · doi:10.3109/01902148809062850 · Cited by 100
Self-citationWarheit, D. B., Carakostas, M. C., Hartsky, M. A., & Hansen, J. F. (1991) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(91)90215-z · Cited by 98
Self-citationRAT LUNG INFLAMMATORY RESPONSES AFTER IN VIVO AND IN VITRO EXPOSURE TO VARIOUS STONE PARTICLES
Becher, R., Hetland, R. B., Refsnes, M., Dahl, J. E., Dahlman, H. J., & Schwarze, P. E. (2001) · Inhalation Toxicology · doi:10.1080/08958370118221 · Cited by 79
In vitro versus in vivo exposure to combustion emissions
Seagrave, J., McDonald, J. D., & Mauderly, J. L. (2005) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2005.05.011 · Cited by 64
Evidence of an oxidative mechanism for the hemolytic activity of silica particles.
Razzaboni, B. L., & Bolsaitis, P. (1990) · Environmental Health Perspectives · doi:10.1289/ehp.9087337 · Cited by 51
Species Comparisons of Proximal Alveolar Deposition Patterns of Inhaled Particulates
Warheit, D. B., & Hartsky, M. A. (1990) · Experimental Lung Research · doi:10.3109/01902149009087874 · Cited by 30
Self-citationEnhancement of haemolytic activity of asbestos by heat-labile factors in fresh serum.
Harington, J. S., MACNAB, G. M., Miller, K., & Pc, K. (1971) · PubMed · Cited by 21
Cited by
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Sharifi, S., Behzadi, S., Laurent, S., Laird Forrest, M., Stroeve, P., & Mahmoudi, M. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15188f · Cited by 1,460
Rasmussen, J. W., Martinez, E., Louka, P., & Wingett, D. G. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.502560 · Cited by 1,330
NanoGenotoxicology: The DNA damaging potential of engineered nanomaterials
Singh, N., Manshian, B., Jenkins, G. J. S., Griffiths, S. M., Williams, P. M., Maffeis, T. G. G., Wright, C. J., & Doak, S. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.009 · Cited by 1,184
Magnetic nanoparticles for theragnostics
Shubayev, V. I., Pisanic, T. R., & Jin, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.007 · Cited by 1,028
Metadata
- Authors
- Sayes, C. M., Reed, K. L., & Warheit, D. B.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-01
- Volume
- 97
- Issue
- 1
- Pages
- 163-180
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2163577514
- Cited by
- 762
- References
- 21
- FWCI
- 38.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.